Leaflet MESALAZINA ALFASIGMA 400mg gastro-resistant tablets

Product code:
W69663001
Quantity:
60
Indicated for:
inflammatory bowel disease
Route of administration:
oral
Substance:
mesalazine (anti-inflammatory agent)
ATC
A07EC02 — Alimentary tract and metabolism | Intestinal antiinflammatory agents | Aminosalicylic acid and similar agents
Mesalazine is a medication used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. It is effective for both inducing remission and maintaining it, helping to reduce inflammation in the intestinal lining.

Mesalazine works locally in the intestine by inhibiting the production of inflammatory substances, such as prostaglandins and leukotrienes. It is available in the form of tablets, suppositories, or enemas, depending on the location of the inflammation in the digestive tract.

Side effects are usually mild and may include nausea, abdominal pain, diarrhea, headache, or skin rashes. In rare cases, more serious reactions can occur, such as kidney or liver dysfunction or severe allergic reactions. It is important to take mesalazine as prescribed by a doctor, with regular blood and urine tests to monitor for potential complications.

General data about MESALAZINA ALFASIGMA 400mg

Substance:
mesalazine
Date of latest medicines list:
01-08-2023
Product code:
W69663001
Concentration:
400mg
Pharmaceutical form:
gastro-resistant tablets
Quantity:
60
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
SOFAR S.P.A. - ITALIA
Holder:
ALFASIGMA S.p.A. - ITALIA
Number:
12452/2019/01
Shelf life:
3 years

Concentrations available for mesalazine

  • 1000mg
  • 1200mg
  • 1g
  • 1g/dose
  • 250mg
  • 2g
  • 400mg
  • 4g/60ml
  • 500mg
  • 800mg